ArticleBiomedicines2025
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).
Abstract read
In one paragraph
Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors.
Yuta NakamuraDepartment of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0003-4950-291X
Ichiro HorieDepartment of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0003-3430-5796
Hiroshi YanoClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0002-5291-968X
Hiroshi NomotoDepartment of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan.ORCID 0000-0003-0713-221X
Tomoyasu FukuiDivision of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa 142-8555, Japan.ORCID 0000-0002-8535-008X
Yoshihiko YuyamaDivision of Pediatrics, Osaka Metropolitan University Graduate School, Osaka 545-8585, Japan.ORCID 0000-0001-9409-8595
Tomoyuki KawamuraDivision of Pediatrics, Osaka Metropolitan University Graduate School, Osaka 545-8585, Japan.ORCID 0000-0002-3593-9910
Mariko UedaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Akane YamamotoDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Yushi HirotaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.ORCID 0000-0002-3035-4155
Yoshiki KusunokiDepartment of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya 663-8501, Japan.ORCID 0000-0002-9361-9317
Kenro NishidaDivision of Diabetes and Endocrinology, Kumamoto Central Hospital, Kumamoto 862-0965, Japan.
Dan SekiguchiMinami Diabetes Clinical Research Center, Clinic Masae Minami, Fukuoka 815-0071, Japan.ORCID 0009-0003-6817-0356
Yasutaka MaedaMinami Diabetes Clinical Research Center, Clinic Masae Minami, Fukuoka 815-0071, Japan.
Masae MinamiMinami Diabetes Clinical Research Center, Clinic Masae Minami, Fukuoka 815-0071, Japan.
Ayako NagayamaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
Shimpei IwataDivision of Endocrinology and Metabolism, Yame General Hospital, Yame 834-0034, Japan.
Hitomi MinagawaDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Shinya FurukawaHealth Services Center, Ehime University, Bunkyo, Matsuyama 790-8577, Japan.ORCID 0000-0002-0041-7688
Teruki MiyakeDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.
Hiroaki UenoDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan.ORCID 0000-0003-4947-594X
Rei ChinenDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology, Graduate School of Medicine, University of the Ryukyus, Nishihara 903-0215, Japan.
Yoshiro NakayamaDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology, Graduate School of Medicine, University of the Ryukyus, Nishihara 903-0215, Japan.
Hiroaki MasuzakiDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology, Graduate School of Medicine, University of the Ryukyus, Nishihara 903-0215, Japan.ORCID 0000-0002-2445-1047
Yasutaka MiyachiDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.ORCID 0000-0002-1487-5153
Yosuke OkadaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.
Mitsuhiro OkamotoDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Kaoru OnoDepartment of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Ken-Ichi TanakaDepartment of Rheumatology and Diabetes, Wakamatsu Hospital of the University of Occupational and Environmental Health, Kitakyushu 808-0024, Japan.
Akira KurozumiDepartment of Rheumatology and Diabetes, Wakamatsu Hospital of the University of Occupational and Environmental Health, Kitakyushu 808-0024, Japan.
Takenori SakaiDepartment of Internal Medicine, Yahatahama City General Hospital, Yahatahama 796-8502, Japan.
Hironori YamasakiDepartment of Diabetes and Endocrinology, Sasebo General Medical Center, Sasebo 857-8511, Japan.
Jun-Ichi YasuiDepartment of Endocrinology and Metabolism, NHO Nagasaki Medical Center, Omura 856-0835, Japan.
Ayako ItoCenter of Diabetes and Endocrinology, Sasebo Central Hospital, Sasebo 857-1165, Japan.
Atsushi KawakamiDepartment of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Norio AbiruDepartment of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
IPRA-CKD Study Group
Funding
Astellas Pharma (Japan) None
Abstract
PubMed holds no abstract for this paper.
Indexed as
chronic kidney diseaseipragliflozinrenal outcomeSGLT2 inhibitortype 1 diabetes
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.